Trump 2.0 spells global change in pharmaceutical regulation, funding and investment
Trump's controversial administration nominees signal global ramifications for drug regulation, health funding and pharmaceutical investment.
ESG
Huawei’s top 10 construction principles for intelligent computing centre facilities
Trump 2.0 spells uncertainty for US healthcare, says analyst
Zentiva voices UWWTD concerns as EU grants approval
FDA approves Journey Medical’s rosacea treatment Emrosi
NCCN visits Vietnam in continued cancer care collaboration
